This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

MedTech Summit

FINAL SAVINGS EXPIRE IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
10 - 14 June 2024
DoubleTree by Hilton Brussels CityBrussels, Belgium (Hybrid Event)

Alison Dennis
Partner at Taylor Wessing
Speaker

Profile

Alison co-heads our international Life Sciences and Healthcare group. She works with international life sciences companies to cut through the complexity of EU regulation of medical devices and pharmaceuticals, and get their products to market.

In a career of over 20 years, Alison has helped hundreds of life sciences companies manage the range of legal challenges involved in commercialising medical devices and medicinal products. She combines an encyclopaedic knowledge of the EU and UK life sciences regulatory environment with an analytical understanding of strategy and business in the life sciences sector.

Alison provides sophisticated advice on regulation, compliance and commercialisation, as well as intellectual property transactions. On a number of occasions, she has successfully persuaded regulators and notified bodies to reconsider and ultimately overturn their decisions, allowing her clients to commercialise new products.

Alison supports clients on outright acquisitions and licences, as well as in due diligence for sizeable corporate transactions and listings. She also helps clients navigate the nuances of structuring and negotiating arrangements with various commercial and health care partners within the complex framework of EU regulations, national laws and industry and deontological codes.

Her clients praise the pragmatism and commercial awareness she brings to every legal challenge and transaction, as well as her bright and personable working style. She is an accomplished leader, having built new life sciences practices for two top-tier London law firms.

Agenda Sessions

  • DUAL DIALOGUE Decoding the Impact of Enhanced Cyber Security Regulations for Medical Devices and IVDs

    10:10

At this event